BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services Contract Manufacturing

Samsung Biologics introduced its CDO process platform, S-Cellerate(TM), at BPI 2021

Samsung Biologics, a global contract development and manufacturing organization (CDMO), introduced its proprietary technology platform, S-CellerateTM, at t...

September 23, 2021 | News

WuXi Biologics Completes SARS-CoV-2 Protein Synthesis for BVX-0320 and CoviDTH

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF)("BioVaxys"), announced that CDMO's global partner WuXi Biologics has completed the syn...

September 15, 2021 | News

GenScript ProBio to Manufacture Innovative Antibody Drug

FLYSYN is a fms-like tyrosine kinase 3 (FLT3) specific antibody for the treatment of acute myeloid leukemia (AML) patients in complete remission. FLYSYN wa...

September 06, 2021 | News

WuXi Biologics Received First Manufacturing License from Japan

WuXi Biologics (WuXi Bio) , a global company with leading open-access biologics technology platforms, today announced that it has received the Manufacturin...

September 02, 2021 | News

WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate

This additional EMA GMP certificate was issued following a remote inspection conducted by Poland's Chief Pharmaceutical Inspectorate in Apri...

August 03, 2021 | News

CliniRx to offer full suite of Rave EDC and CDM services to sponsors

CliniRx has achieved accreditation as a CRO partner for Medidata Rave EDC, joining Medidata's industry-leading partner program to furt...

July 30, 2021 | News

Marker Therapeutics Announces Opening of New cGMP Manufacturing Facility

Marker Therapeutics, Inc. a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapi...

July 30, 2021 | News

WuXi Biologics Received First GMP manufacturing authorization outside of China

First GMP manufacturing authorization outside of China, validating WuXi Biologics' world-class quality system Only 12 months from facility qualific...

July 26, 2021 | News

Vetter Site status now ‘ready for media fill’

Vetter, a leading global Contract Development and Manufacturing Organization (CDMO) has further invested in additional capacity to meet this growin...

July 21, 2021 | News

Samsung Biologics and Kineta Announce CDMO Agreement

Kineta to leverage Samsung Biologics' development and manufacturing expertise to advance KVA12.1 to IND Samsung Biologics San Francisco R&D cent...

July 21, 2021 | News

Novotech expands virtual clinical trials capabilities

The round was led by two new partners: Dedalus Group a leading healthcare and diagnostic software provider in Europe backed by Ardian, and Novotech H...

July 19, 2021 | News

Lonza Extends Collaboration with Major Biopharmaceutical Partner

Long-term collaboration for commercial supply of monoclonal antibodies will complete the integrated supply chain for the manufacture of an antibody-drug ...

July 17, 2021 | News

Merck and Universal Agree on the large-scale production of a new pediatric medication.

Merck has entered into a contract manufacturing agreement with Universal Corporation Ltd., Nairobi, Kenya, for the large-scale production of a new pediatri...

July 16, 2021 | News

Bora Group announce the rebranding of Yuta Health to Bora Health

With the name change, Bora plans to complete the merging of the operations of Bora Health and Union Chemical & Pharmaceutical by the end of 2021. In th...

July 06, 2021 | News

Stay Connected